Search Results - "Irfan, Cicin"

Cancer-related hypercalcemia and potential treatments by Almuradova, Elvina, Cicin, Irfan

“…Cancer-related hypercalcemia is a common finding typically seen in patients with advanced cancer and occurs in about 20 to 30 percent of cases. The most common…”
Get full text

Efficacy and safety of cabozantinib for patients with advanced hepatocellular carcinoma based on albumin-bilirubin grade by Kelley, Robin Kate, Miksad, Rebecca, Cicin, Irfan, Chen, YenHsun, Klümpen, Heinz-Josef, Kim, Stefano, Lin, Zhong-Zhe, Youkstetter, Jillian, Hazra, Saswati, Sen, Suvajit, Cheng, Ann-Lii, El-Khoueiry, Anthony B., Meyer, Tim, Abou-Alfa, Ghassan K.

“…Background Albumin-bilirubin (ALBI) grade is an objective measure of liver function for patients with hepatocellular carcinoma (HCC). The tyrosine kinase…”
Get full text

Efficacy and safety of trifluridine/tipiracil in older and younger patients with metastatic gastric or gastroesophageal junction cancer: subgroup analysis of a randomized phase 3 study (TAGS) by Shitara, Kohei, Doi, Toshihiko, Hosaka, Hisashi, Thuss-Patience, Peter, Santoro, Armando, Longo, Federico, Ozyilkan, Ozgur, Cicin, Irfan, Park, David, Zaanan, Aziz, Pericay, Carles, Özgüroğlu, Mustafa, Alsina, Maria, Makris, Lukas, Benhadji, Karim A., Ilson, David H.

“…Background Trifluridine and tipiracil (FTD/TPI) demonstrated survival benefit vs placebo and manageable safety in previously treated patients with metastatic…”
Get full text

Investigation of the relationship between GSTM1 gene variations and serum trace elements, plasma malondialdehyde levels in patients with colorectal cancer by Ay, Arzu, Gulyasar, Tevfik, Alkanli, Nevra, Sipahi, Tammam, Cicin, Irfan, Kocak, Zafer, Sut, Necdet

“…Background The aim of this study is to investigate of the relationship between GSTM1 gene variations and serum trace elements, plasma malondialdehyde levels in…”
Get full text

Epacadostat plus pembrolizumab versus placebo plus pembrolizumab for advanced urothelial carcinoma: results from the randomized phase III ECHO-303/KEYNOTE-698 study by Cicin, Irfan, Plimack, Elizabeth R, Gurney, Howard, Leibowitz, Raya, Alekseev, Boris Y, Parnis, Francis X, Peer, Avivit, Necchi, Andrea, Bellmunt, Joaquim, Nishiyama, Hiroyuki, Clark, Jason, Munteanu, Mihaela, Kataria, Ritesh, Jia, Calvin, Powles, Thomas, Sternberg, Cora N

“…Indoleamine 2,3-dioxygenase 1 (IDO1) levels correlate with poor outcomes in urothelial carcinoma (UC). IDO1 and programmed death-ligand 1 (PD-L1) are often…”
Get full text

Recurrent delayed immune-related pneumonitis after immune-checkpoint inhibitor therapy for advanced osteosarcoma by Küçükarda, Ahmet, Gökmen, İvo, Özcan, Erkan, Peker, Pınar, Akgül, Fahri, Çiçin, İrfan

“…The case of a patient who developed recurrent delayed immune-related pneumonitis (checkpoint inhibitor pneumonitis [CIP]) after immune checkpoint inhibitor…”
Get full text

Relationship between prognostic nutritional index and neutrophil lymphocyte ratio with overall survival in patients with metastatic colorectal cancer receiving regorafenib by Erdogan, Bulent, Ozcan, Erkan, Gokmen, Ivo, Gokyer, Ali, Kucukarda, Ahmet, Kostek, Osman, Hacioglu, Muhammet, Uzunoglu, Sernaz, Cicin, Irfan

“…Aim: In this study, we aimed to analyze the effect of prognostic nutritional index and neutrophile lymphocyte ratio on the overall survival (OS) in patients…”
Get full text

Effect of clinical and pathological features of gastrointestinal stromal tumors on overall survival and prognosis: Single center experience by Merev, Elif, Cicin, Irfan

“…Gastrointestinal stromal tumors (GIST) are the most common mesenchymal tumors of the gastrointestinal tract. We aimed to evaluate the clinicopathological…”
Get full text

Economic burden of lung cancer in Turkey: A cost of illness study from payer perspective by Cicin, Irfan, Oksuz, Ergun, Karadurmus, Nuri, Malhan, Simten, Gumus, Mahmut, Yilmaz, Ulku, Cansever, Levent, Cinarka, Halit, Cetinkaya, Erdogan, Kiyik, Murat, Ozet, Ahmet

“…Background: This study was designed to estimate economic burden of lung cancer in Turkey from payer perspective based on expert panel opinion on practice…”
Get full text

Efficacy and safety results by menopausal status in monarchE: adjuvant abemaciclib combined with endocrine therapy in patients with HR+, HER2−, node-positive, high-risk early breast cancer by Paluch-Shimon, Shani, Neven, Patrick, Huober, Jens, Cicin, Irfan, Goetz, Matthew P., Shimizu, Chikako, Huang, Chiun-Sheng, Lueck, Hans Joachim, Beith, Jane, Tokunaga, Eriko, Contreras, Jessica Reyes, de Sant’Ana, Rosane Oliveira, Wei, Ran, Shahir, Ashwin, Nabinger, Sarah C., Forrester, Tammy, Johnston, Stephen R. D., Harbeck, Nadia

“…Background: Abemaciclib is the first and only cyclin-dependent kinases 4 and 6 inhibitor approved for adjuvant treatment of hormone receptor-positive (HR+),…”
Get full text

Perceptions and Expectations: A Study on Prognostic Perception and Quality of Life in Patients With Metastatic Renal and Bladder Cancer by Bolek, Hatice, Arslan, Cagatay, Basaran, Mert, Cicin, İrfan, Ozguroglu, Mustafa, Tural, Deniz, Ürün, Yüksel

“…Durable complete response rates for metastatic renal cell carcinoma (mRCC) and metastatic bladder cancer (mBC) are low despite new therapy. Palliative care…”
Get full text

The relationship between prognostic nutritional index and treatment response in patients with metastatic renal cell cancer by Yasar, Hatime Arzu, Bir Yucel, Kadriye, Arslan, Cagatay, Ucar, Gokhan, Karakaya, Serdar, Bilgin, Burak, Taban, Hakan, Kucukarda, Ahmet, Erturk, Ismail, Hızal, Mutlu, Yıldız, Birol, Yıldırım, Nuriye, Demirci, Umut, Sendur, Mehmet Ali, Utkan, Gungor, Kılıckap, Saadettin, Cicin, Irfan, Karadurmus, Nuri, Ürün, Yüksel

“…Introduction and aim To investigate the effect of the prognostic nutritional index on treatment response and survival in patients with metastatic renal cell…”
Get full text

Safety, efficacy and patient-reported outcomes with trifluridine/tipiracil in pretreated metastatic colorectal cancer: results of the PRECONNECT study by Bachet, Jean-Baptiste, Wyrwicz, Lucjan, Price, Timothy, Cremolini, Chiara, Phelip, Jean-Marc, Portales, Fabienne, Ozet, Ahmet, Cicin, Irfan, Atlan, Dan, Becquart, Martin, Vidot, Loick, Mounedji, Nadjat, Van Cutsem, Eric, Taieb, Julien, Falcone, Alfredo

“…In RECOURSE (, trifluridine/tipiracil significantly improved overall survival and progression-free survival (PFS) versus placebo in patients with pretreated…”
Get full text

Concordance of PD-L1 expression and CD8+ TIL intensity between NSCLC and synchronous brain metastases by Batur, Sebnem, Dulger, Onur, Durak, Sermin, Yumuk, Perran Fulden, Caglar, Hale Basak, Bozkurtlar, Emine, Bozkurt, Suheyla, Tastekin, Ebru, Cicin, Irfan, Ahiskali, Rengin, Rzazade, Rashad, Cakir, Asli, Oz, Buge

“…Programmed death-ligand 1 (PD-L1) is suggested to be a predictive biomarker in non-small-cell lung carcinoma (NSCLC). However, the differential expression of…”
Get full text

Real-world Treatment Sequencing in Patients with Metastatic Castration-resistant Prostate Cancer: Results from the Prospective, International, Observational Prostate Cancer Registry by Bjartell, Anders, Costa, Luis, Kramer, Gero, Zurawski, Bogdan, Galli, Luca, Werbrouck, Patrick, Ecke, Thorsten, Parikh, Omi, Bennamoun, Mostefa, Garcia Freire, Camilo, Peer, Avivit, Ljungberg, Börje, Cicin, Irfan, Smith, Emma, Lukac, Martin, Wapenaar, Robert, Chowdhury, Simon

“…Patient characteristics appear to influence the first-line treatment of metastatic castration-resistant prostate cancer. Patients older and with lower Gleason…”
Get full text

Tyrosine kinase inhibitors in the treatment of metastatic renal cell cancer patients with early cytokine intolerance: TURCOS, a Turkish national, prospective observational study by Benekli, Mustafa, Gumus, Mahmut, Ozkan, Metin, Dane, Faysal, Elkiran, Emin T., Cicin, Irfan, Sevinc, Alper, Aliustaoglu, Mehmet, Isikdogan, Abdurrahman, Meydan, Nezih, Oksuzoglu, Berna, Ozyilkan, Ozgur, Artac, Mehmet, Ozdemir, Feyyaz, Kilickap, Sadettin

“…Objective Cytokines have been the mainstay of treatment in metastatic renal cell cancer (mRCC) for decades before the introduction of tyrosine kinase…”
Get full text

Impact of dose reductions on adjuvant abemaciclib efficacy for patients with high-risk early breast cancer: analyses from the monarchE study by Goetz, Matthew P., Cicin, Irfan, Testa, Laura, Tolaney, Sara M., Huober, Jens, Guarneri, Valentina, Johnston, Stephen R. D., Martin, Miguel, Rastogi, Priya, Harbeck, Nadia, Shahir, Ashwin, Wei, Ran, André, Valérie, Rugo, Hope S., O’Shaughnessy, Joyce

“…In monarchE, adjuvant abemaciclib significantly improved invasive disease-free survival (IDFS) and distant relapse-free survival (DRFS), with sustained benefit…”
Get full text

Prognostic factors for regorafenib treatment in patients with refractory metastatic colorectal cancer: A real-life retrospective multi-center study by Goktas Aydin, Sabin, Kavak, Engin Eren, Topcu, Atakan, Bayramgil, Ayberk, Akgul, Fahri, Kahraman, Seda, Aykan, Musa Baris, Altıntas, Yunus Emre, Helvaci, Kaan, Urun, Yuksel, Bilici, Ahmet, Seker, Mesut, Sendur, Mehmet Ali Nahit, Olmez, Omer Fatih, Acikgoz, Ozgur, Cicin, Irfan

“…Regorafenib, an oral multikinase inhibitor, has improved survival in metastatic colorectal cancer (mCRC) patients who have progressed on standard therapies…”
Get full text

Neutrophil–lymphocyte ratio as a prognostic factor for survival in patients with advanced renal cell carcinoma (Turkish Oncology Group Study) by Hizal, Mutlu, Sendur, Mehmet AN, Yasar, Hatime Arzu, Bir Yucel, Kadriye, Arslan, Cagatay, Ucar, Gokhan, Karakaya, Serdar, Taban, Hakan, Kucukarda, Ahmet, Erturk, Ismail, Bilgin, Burak, Yıldırım, Nuriye, Demirci, Umut, Kılıckap, Saadettin, Cicin, Irfan, Karadurmus, Nuri, Yalcin, Bulent, Ürün, Yüksel

“…Background To describe the prognostic value of neutrophil–lymphocyte ratio and its effect on survival in in patients with advanced renal cell carcinoma…”
Get full text

An Open-Label, Multinational, Multicenter, Phase IIIb Study with Subcutaneous Administration of Trastuzumab in Patients with HER2-Positive Early Breast Cancer to Evaluate Patient Satisfaction by Cicin, İrfan, Oukkal, Mohammed, Mahfouf, Hassen, Mezlini, Amel, Larbaoui, Blaha, Ahmed, Slim Ben, Errihani, Hassan, Alsaleh, Khalid, Belbaraka, Rhizlane, Yumuk, Perran Fulden, Goktas, Burce, Özgüroğlu, Mustafa

“…This study was designed to investigate treatment satisfaction in patients and Health Care Professionals (HCP) and to evaluate the safety and tolerability of…”
Get full text